AnaptysBio (MEX:ANAB) Inventories, Raw Materials & Components: MXN0 Mil (As of Mar. 2026)


MEX:ANAB AnaptysBio Inc MEX:ANAB
66 GF Score
Price MXN445.25
GF Value MXN417.03
! 5 Warning Signs
View Full Analysis

What is AnaptysBio Inventories, Raw Materials & Components?

AnaptysBio MEX:ANAB 66 Inventories, Raw Materials & Components is MXN0 Mil as of Mar. 2026. GuruFocus rates MEX:ANAB with a GF Score™ of 66/100 and a GF Value™ of MXN417.03. The stock has 5 warning signs investors should review.

AnaptysBio's inventories, raw materials & components for the quarter that ended in Mar. 2026 was MXN0 Mil.

AnaptysBio Inventories, Raw Materials & Components Historical Data

* Premium members only.

The historical data trend for AnaptysBio's Inventories, Raw Materials & Components can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AnaptysBio Inventories, Raw Materials & Components Chart

AnaptysBio Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Raw Materials & Components
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

AnaptysBio Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Raw Materials & Components Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
MEX:ANAB
66GF Score
AnaptysBio Inc MEX:ANAB
Inventories, Raw Materials & Components is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AnaptysBio Inventories, Raw Materials & Components Calculation

Materials and components scheduled for use in making a product.

What does a Inventories, Raw Materials & Components of MXN0 Mil mean?
AnaptysBio (MEX:ANAB) has a Inventories, Raw Materials & Components of MXN0 Mil as of Mar. 2026. Raw materials are the components a company uses for its main products. View historical data on AnaptysBio and its competitors.
Is AnaptysBio's Inventories, Raw Materials & Components too high?
AnaptysBio's current Inventories, Raw Materials & Components is MXN0 Mil. Overall, AnaptysBio has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does AnaptysBio's Inventories, Raw Materials & Components compare to ABSI and TSHA?
AnaptysBio's Inventories, Raw Materials & Components of MXN0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Raw Materials & Components for a Biotechnology company?
A good Inventories, Raw Materials & Components depends on the Biotechnology industry context. However, Inventories, Raw Materials & Components should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Raw Materials & Components mean?
A high Inventories, Raw Materials & Components can signal that a stock is expensive relative to its fundamentals. Raw materials are the components a company uses for its main products. View historical data on AnaptysBio and its competitors. AnaptysBio's current Inventories, Raw Materials & Components is MXN0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AnaptysBio stock overvalued right now?
AnaptysBio (MEX:ANAB) has a current Inventories, Raw Materials & Components of MXN0 Mil. The stock's GF Value™ is MXN417.03, compared to a current price of MXN445.25 — trading 6.8% above its estimated fair value. The current Inventories, Raw Materials & Components is MXN0 Mil. AnaptysBio's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Raw Materials & Components calculated?
Inventories, Raw Materials & Components is calculated from a company's financial statements. For AnaptysBio (MEX:ANAB), the current Inventories, Raw Materials & Components is MXN0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AnaptysBio (MEX:ANAB) Overvalued in 2026?

Based on GuruFocus' analysis, AnaptysBio stock appears to be overvalued. The current stock price of MXN445.25 is trading 6.8% above its estimated GF Value™ of MXN417.03.

Key valuation signals for MEX:ANAB:

  • Inventories, Raw Materials & Components: MXN0 Mil
  • GF Value™: MXN417.03 vs. price of MXN445.25 (6.8% above fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the MEX:ANAB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AnaptysBio Business Description

Other Exchanges ANAB:USA0HFQ:UKAN6:Germany
Address 10770 Wateridge Circle, Suite 210, San Diego, CA, USA, 92121
AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).
66GF Score

Get the complete analysis for MEX:ANAB

Inventories, Raw Materials & Components is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN445.25
Price
MXN417.03
GF Value